Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - CASH & EQUIVALENTS
Cash & Equivalents VKTX - Viking Therapeutics, Inc.
55.5 M
LAST VALUE
45.09%
2 YEAR CAGR
17.51%
5 YEAR CAGR
77.42%
10 YEAR CAGR